Public Page
AURIMOD is a Vienna-based, commercial-stage MedTech pioneering a new approach to treating chronic pain. Its CE-marked wearable VIVO® sits behind the ear and activates the body’s own pain regulation, offering a drug-free alternative. Reimbursed in Austria and active in nine countries, with nearly 4,000 patients expected by year-end, AURIMOD is scaling through further markets and indications.
Request access to the full data room to review financials, documents and due diligence materials.